| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Apellis Pharmaceuticals IncAPLS | +129.35% | $17.89 | $41.03 | 2026-03-17 - 2026-05-15 | Strong Buy |
Apellis Pharmaceuticals IncAPLS | +92.36% | $21.33 | $41.03 | 2026-01-12 - 2026-05-15 | Strong Buy |
Apellis Pharmaceuticals IncAPLS | +78.78% | $22.95 | $41.03 | 2025-07-31 - 2026-05-15 | Strong Buy |
Camp4 Therapeutics CorpCAMP | +40.60% | $2.98 | $4.19 | 2025-10-01 - 2026-06-12 | Strong Buy |
Harrow IncHROW | +26.20% | $29.83 | $37.64 | 2026-05-12 - 2026-06-12 | Strong Buy |
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Aligos Therapeutics IncALGS | 1 | Strong Buy | $20.00 | +278.79% | Initiates Coverage On | 23 days ago |
Harrow IncHROW | 3 | Strong Buy | $88.00 | +133.79% | Maintains | a month ago |
Inflarx NvIFRX | 1 | Strong Buy | $4.00 | +150.00% | Maintains | a month ago |
Abcellera Biologics IncABCL | 1 | Strong Buy | $7.00 | +33.59% | Initiates Coverage On | a month ago |
Viking Therapeutics IncVKTX | 1 | Strong Buy | $100.00 | +247.83% | Maintains | a month ago |
Opus Genetics IncIRD | 1 | Strong Buy | $15.00 | +271.29% | Initiates Coverage On | 2 months ago |
Surrozen IncSRZN | 2 | Strong Buy | $40.00 | +71.01% | Reiterates | 3 months ago |
Apellis Pharmaceuticals IncAPLS | 3 | Strong Buy | $31.00 | -24.45% | Maintains | 3 months ago |
Korro Bio IncKRRO | 2 | Strong Buy | $22.00 | +89.49% | Maintains | 3 months ago |
Belite Bio IncBLTE | 2 | Strong Buy | $266.00 | +92.53% | Maintains | 3 months ago |
Wave Life Sciences LtdWVE | 2 | Strong Buy | $41.00 | +598.47% | Maintains | 4 months ago |
Xencor IncXNCR | 2 | Strong Buy | $42.00 | +240.63% | Maintains | 7 months ago |
Innoviva IncINVA | 2 | Strong Buy | $31.00 | +36.32% | Maintains | 7 months ago |
Camp4 Therapeutics CorpCAMP | 1 | Strong Buy | $7.00 | +67.06% | Initiates Coverage On | 8 months ago |
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $52.00 | +1,869.70% | Initiates Coverage On | a year ago |